KurneA, ErtugrulA, Anil YagciogluAE, YaziciKM. Venous thromboembolism and escitalopram. Gen Hosp Psychiatry2004; 26:481–3. DOI 10.1016/j.genhosppsych.2004.06.003
2.
RamasubbuR. SSRI treatment-associated stroke: causality assessment in two cases. Ann Pharmacother2004; 38:1197–201. DOI 10.1345/aph.1D624
3.
SinghaiAB, CavinessVS, BegleiterAF, MarkEJ, RordorfG, KoroshetzWJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology2002; 58:130–3.
4.
NaranjoCA, BustoU, SellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30:239–45.
5.
GilonD, BuonannoFS, JoffeMM. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med1999; 341:8–13.
6.
VakilianA, IranmaneshF. Assessment of cerebrovascular reactivity during major depression and after remission of disease. Ann Indian Acad Neurol2010; 13:52–6. DOI 10.4103/0972–2327.61278
7.
CerritoF, LazzanoMP, GaudioE, ArminioP, AloisiG. 5HT2-receptors and serotonin release: their role in human platelet aggregation. Life Sci1993; 53:209–15. DOI 10.1016/0024–3205(93)90671–0
8.
NoskinO, JafarimojarradE, LibmanRB, NelsonJL. Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants. Neurology2006; 67:159–60.
